These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36129921)

  • 1. Pyrazinamide resistance in rifampicin discordant tuberculosis.
    Mvelase NR; Singh R; Swe Swe-Han K; Mlisana KP
    PLoS One; 2022; 17(9):e0274688. PubMed ID: 36129921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
    Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
    Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
    Tahseen S; Khanzada FM; Rizvi AH; Qadir M; Ghazal A; Baloch AQ; Mustafa T
    PLoS One; 2020; 15(9):e0239328. PubMed ID: 32966321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Dookie N; Sturm AW; Moodley P
    BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
    BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
    Mushtaq F; Raza SM; Ahmad A; Aslam H; Adeel A; Saleem S; Ahmad I
    PLoS One; 2023; 18(10):e0293194. PubMed ID: 37883448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalences of levofloxacin resistance and
    Ng KKM; Yip PCW; Leung PKL
    Hong Kong Med J; 2021 Dec; 27(6):421-427. PubMed ID: 34949730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among
    Haratiasl AA; Hamzelou G; Amini S; Kardan-Yamchi J; Haeili M; Heidari F; Feizabadi MM
    J Chemother; 2020 Apr; 32(2):75-82. PubMed ID: 32009582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    Farhat MR; Sixsmith J; Calderon R; Hicks ND; Fortune SM; Murray M
    J Antimicrob Chemother; 2019 Jun; 74(6):1477-1483. PubMed ID: 30793747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
    Fasih N; Rafiq Y; Jabeen K; Hasan R
    PLoS One; 2012; 7(11):e50551. PubMed ID: 23226311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinamide resistance due to pncA gene mutation and its association with treatment outcome among tuberculosis patients of South India- A longitudinal observational study.
    Xavier V AM; R M; Joseph NM; Ellappan K; Muthuraj M
    Indian J Tuberc; 2024; 71 Suppl 1():S81-S85. PubMed ID: 39067961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The past, present and future of tuberculosis treatment.
    Bi K; Cao D; Ding C; Lu S; Lu H; Zhang G; Zhang W; Li L; Xu K; Li L; Zhang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 51(6):657-668. PubMed ID: 36915970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.